SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-020275
Filing Date
2024-03-06
Accepted
2024-03-06 07:10:12
Documents
16
Period of Report
2024-03-06

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0201262-6k_kamada.htm 6-K 13377
2 KAMADA REPORTS STRONG FISCAL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS, AND ea0201262ex99-1_kamada.htm EX-99.1 169051
3 KAMADA 2023 RESULTS PRESENTATION ea0201262ex99-2_kamada.htm EX-99.2 18073
4 KAMADA ISSUES 2024 CEO LETTER TO SHAREHOLDERS ea0201262ex99-3_kamada.htm EX-99.3 32596
5 GRAPHIC ex99-2_001.jpg GRAPHIC 105250
6 GRAPHIC ex99-2_002.jpg GRAPHIC 498832
7 GRAPHIC ex99-2_003.jpg GRAPHIC 287748
8 GRAPHIC ex99-2_004.jpg GRAPHIC 176428
9 GRAPHIC ex99-2_005.jpg GRAPHIC 233370
10 GRAPHIC ex99-2_006.jpg GRAPHIC 259868
11 GRAPHIC ex99-2_007.jpg GRAPHIC 290168
12 GRAPHIC ex99-2_008.jpg GRAPHIC 311348
13 GRAPHIC ex99-2_009.jpg GRAPHIC 279319
14 GRAPHIC ex99-2_010.jpg GRAPHIC 287748
15 GRAPHIC ex99-2_011.jpg GRAPHIC 54280
16 GRAPHIC ex99-2_012.jpg GRAPHIC 193694
  Complete submission text file 0001213900-24-020275.txt   4336503
Mailing Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402
Business Address 2 HOLTZMAN ST., SCIENCE PARK REHOVOT L3 7670402 97289406472
KAMADA LTD (Filer) CIK: 0001567529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35948 | Film No.: 24724352
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)